Editorial Team
🇺🇸 FDANamed contributors covering United States & Americas pharmaceutical intelligence — 8 editors with published articles.
Quick answer
NovaPharmaNews United States & Americas edition lists 8 named editorial contributors with 1,527 published articles — FDA drug approvals, clinical trials, manufacturing, and market intelligence attributed to accountable experts.
Contributors
- Dr. Sarah Mitchell PharmD, RPh Senior FDA Regulatory Correspondent 1,178 articles Dr. Mitchell has over 15 years of experience covering FDA drug approvals and regulatory policy.
- James Chen, PharmD PharmD, BCPS Clinical Trials Editor 93 articles James covers Phase III clinical trials and breakthrough therapy designations across the Americas.
- Dr. Laura Bennett PharmD, MPH Senior FDA Policy Correspondent 90 articles Dr. Laura Bennett covers FDA review pathways and late-stage oncology approvals. She previously advised two US biotech companies on regulatory submission strategy and has spent 17 years tracking policy shifts that impact clinical development timelines.
- Dr. Emily Carter PhD, Chemical Engineering Pharma Manufacturing and CMC Analyst 37 articles Dr. Emily Carter reports on manufacturing scale-up, CMC strategy, and quality remediation in global pharma networks. Her 14 years in process development and technical operations inform practical commentary on supply reliability and launch readiness.
- Dr. Natalie Hughes PharmD Early Career Regulatory Writer 35 articles Dr. Natalie Hughes tracks fast-moving FDA guidance, label changes, and review trends impacting small and mid-cap biotech. She brings 4 years of focused reporting with a strong emphasis on operational takeaways for lean teams.
- Daniel Brooks BS, Molecular Biology Emerging Therapeutics Staff Writer 33 articles Daniel Brooks focuses on next-generation therapeutics, from IND filings through early proof-of-concept studies. In 6 years covering US biotech, he has developed a strong track record in identifying programs likely to shape future standards of care.
- Michael Rivera MS, Biotechnology Biotech Markets Reporter 31 articles Michael Rivera reports on biotech capital markets, licensing activity, and quarterly pipeline inflections. Over 9 years, he has built a data-driven coverage style focused on how scientific milestones translate into commercial outcomes.
- Dr. Priya Nandakumar MBBS, MSc Clinical Research Clinical Trials Intelligence Editor 30 articles Dr. Priya Nandakumar specializes in trial readouts and protocol strategy across immunology and rare disease programs. She has 12 years of experience translating complex endpoints into clear insights for pharma operators and investors.
Frequently asked questions
Who are the NovaPharmaNews editorial contributors?
This directory lists regional editors and analysts with published intelligence on NovaPharmaNews. Each profile shows credentials, coverage focus, and a full article archive for transparency and E-E-A-T.
How is regional coverage organised?
Authors are grouped by regional edition — Americas (FDA), Europe (EMA), or Asia-Pacific (PMDA/NMPA). Open a profile to see that contributor’s published news and analysis.
Where can I read the editorial standards?
See our Editorial Policy and Methodology pages for sourcing rules, correction process, and how human experts validate AI-assisted analysis.